Rein Therapeutics Inc. announced that its Board of Directors approved an amendment to the company's Amended and Restated By-laws. The amendment, effective immediately, specifies that a quorum at all stockholder meetings will require forty percent of the shares of capital stock issued and outstanding and entitled to vote, whether present in person, by remote communication, or represented by proxy.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.